Literature DB >> 20373896

Oxidative stress markers in patients with primary open-angle glaucoma.

Asaad A Ghanem1, Lamiaa F Arafa, Ayman El-Baz.   

Abstract

PURPOSE: To investigate the levels of antioxidant enzymes catalase (CAT), glutathione peroxidase (GPO), superoxide dismutase (SOD), and malondialdehyde (MDA) in human eyes with primary open-angle glaucoma (POAG) and to correlate their concentrations with severity of glaucoma.
DESIGN: A prospective cases control study. PATIENTS AND METHODS: Thirty patients with primary open-angle glaucoma and twenty-five patients with senile cataracts of matched age and gender were included in the study prospectively. Aqueous humor samples were obtained by paracentesis at the time of elective surgery for glaucomatous and cataractous patients. Aqueous humor were analyzed for CAT, GPO, SOD, and MDA status.
RESULTS: GPO, SOD, and MDA enzyme levels revealed a high significant increase in aqueous humor of POAG patients with respect to the comparative group of cataract patients (P < 0.001). No significant difference in the activity of CAT enzyme in aqueous humor of POAG and cataract patient (P = 0.201). Significant correlation was found between the MDA enzyme level and severe visual field loss (P < 0.001) in POAG patients.
CONCLUSION: Increased levels of aqueous humor GPO, SOD, and MDA may be associated with POAG. In addition, they may be useful antioxidant enzyme levels in aqueous humor of POAG patients as a result of glaucoma disease and not a cause.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20373896     DOI: 10.3109/02713680903548970

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  41 in total

1.  Antioxidative flavonol glycosides from the flowers of Abelmouschus manihot.

Authors:  Yi Zhang; Wei He; Chunmei Li; Qiu Chen; Lifeng Han; Erwei Liu; Tao Wang
Journal:  J Nat Med       Date:  2012-03-10       Impact factor: 2.343

Review 2.  Neurodegeneration in glaucoma: progression and calcium-dependent intracellular mechanisms.

Authors:  S D Crish; D J Calkins
Journal:  Neuroscience       Date:  2010-12-25       Impact factor: 3.590

3.  Activation of TLR3 promotes the degeneration of retinal ganglion cells by upregulating the protein levels of JNK3.

Authors:  Shravan K Chintala; Nahrain Putris; Mason Geno
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-01-06       Impact factor: 4.799

4.  Oxidative Stress-Related Molecular Biomarker Candidates for Glaucoma.

Authors:  Gözde Hondur; Emre Göktas; Xiangjun Yang; Lama Al-Aswad; James D Auran; Dana M Blumberg; George A Cioffi; Jeffrey M Liebmann; Leejee H Suh; Danielle Trief; Gülgün Tezel
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-08-01       Impact factor: 4.799

5.  Adeno-associated virus mediated SOD gene therapy protects the retinal ganglion cells from chronic intraocular pressure elevation induced injury via attenuating oxidative stress and improving mitochondrial dysfunction in a rat model.

Authors:  Wenmin Jiang; Luosheng Tang; Jun Zeng; Baihua Chen
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

6.  Evaluation of serum and aqueous humor klotho levels in pseudoexfoliation syndrome, pseudoexfoliation and primary open-angle glaucoma.

Authors:  Ecem Onder Tokuc; Nursen Yuksel; Hale Maral Kır; Esra Acar
Journal:  Int Ophthalmol       Date:  2021-03-18       Impact factor: 2.031

7.  Amyloid fibril formation by the glaucoma-associated olfactomedin domain of myocilin.

Authors:  Susan D Orwig; Christopher W Perry; Laura Y Kim; Katherine C Turnage; Rong Zhang; Douglas Vollrath; Ingeborg Schmidt-Krey; Raquel L Lieberman
Journal:  J Mol Biol       Date:  2011-12-13       Impact factor: 5.469

8.  Black currant anthocyanins normalized abnormal levels of serum concentrations of endothelin-1 in patients with glaucoma.

Authors:  Kaori Yoshida; Ikuyo Ohguro; Hiroshi Ohguro
Journal:  J Ocul Pharmacol Ther       Date:  2012-12-21       Impact factor: 2.671

9.  Gout and open-angle glaucoma risk in a veteran population.

Authors:  Kristin S Biggerstaff; Donna L White; Benjamin J Frankfort; Peter Richardson; Silvia Orengo-Nania; Jose Garcia; Elizabeth Y Chiao; Jennifer R Kramer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-07-17       Impact factor: 3.117

10.  Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma.

Authors:  Wesley S Bond; Jessica Hines-Beard; YPaul L GoldenMerry; Mara Davis; Alma Farooque; Rebecca M Sappington; David J Calkins; Tonia S Rex
Journal:  Mol Ther       Date:  2015-10-27       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.